Critical Comparison: BETA Technologies (NYSE:BETA) vs. Mainz Biomed (NASDAQ:MYNZ)

Mainz Biomed (NASDAQ:MYNZ) and BETA Technologies (NYSE:BETA) are both industrials companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Mainz Biomed and BETA Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
BETA Technologies	-1,913.91%	-96.24%	-48.20%

Analyst Recommendations

This is a summary of current ratings and price targets for Mainz Biomed and BETA Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1	1	0	0	1.50
BETA Technologies	1	1	9	0	2.73

BETA Technologies has a consensus price target of $31.11, indicating a potential upside of 41.04%. Given BETA Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe BETA Technologies is more favorable than Mainz Biomed.

Earnings and Valuation

This table compares Mainz Biomed and BETA Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659,935.00	18.26	-$21.65 million	($65.60)	-0.02
BETA Technologies	$35.62 million	139.61	-$745.87 million	($13.02)	-1.69

Mainz Biomed has higher earnings, but lower revenue than BETA Technologies. BETA Technologies is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Summary

BETA Technologies beats Mainz Biomed on 6 of the 11 factors compared between the two stocks.

About Mainz Biomed

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

About BETA Technologies

BETA Technologies Inc. is an electric aerospace company. It involved in designing, manufacturing and selling high-performance electric aircraft, advanced electric propulsion systems, components and charging systems. BETA Technologies Inc. is based in SOUTH BURLINGTON.